Omalizumab for Aspirin-Hypersensitivity and Leukotriene Overproduction in Aspirin-Exacerbated Respiratory Disease: A Randomized Trial.

Hiroaki Hayashi,Yuma Fukutomi,Chihiro Mitsui,Keiichi Kajiwara,Kentaro Watai,Yosuke Kamide,Yuto Nakamura,Yuto Hamada,Yasuhiro Tomita,Kiyoshi Sekiya,Takahiro Tsuburai,Kenji Izuhara,Keiko Wakahara,Naozumi Hashimoto,Yoshinori Hasegawa,Masami Taniguchi

Omalizumab for Aspirin-Hypersensitivity and Leukotriene Overproduction in Aspirin-Exacerbated Respiratory Disease: A Randomized Trial.

2020

Hiroaki Hayashi
Yuma Fukutomi
Chihiro Mitsui
Keiichi Kajiwara
Kentaro Watai
Yosuke Kamide
Yuto Nakamura
Yuto Hamada
Yasuhiro Tomita
Kiyoshi Sekiya
Takahiro Tsuburai
Kenji Izuhara
Keiko Wakahara
Naozumi Hashimoto
Yoshinori Hasegawa
Masami Taniguchi

Rationale: Aspirin-exacerbated respiratory disease is characterized by severe asthma, non-steroidal anti-inflammatory drug hypersensitivity, nasal polyposis, and leukotriene overproduction. Systemi...

Keywords:

Leukotriene
Anesthesia
Omalizumab
Gastroenterology
Overproduction
Internal medicine
Aspirin
Randomized controlled trial
Medicine
Aspirin exacerbated respiratory disease
Diabetes mellitus
Leukotriene E4
Respiratory disease
aspirin hypersensitivity

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations